Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Utah Medical Products (UTMD) FCF Margin (2016 - 2025)

Utah Medical Products (UTMD) has 16 years of FCF Margin data on record, last reported at 39.25% in Q3 2025.

  • For Q3 2025, FCF Margin rose 160.0% year-over-year to 39.25%; the TTM value through Sep 2025 reached 35.93%, down 244.0%, while the annual FY2024 figure was 35.7%, 739.0% down from the prior year.
  • FCF Margin reached 39.25% in Q3 2025 per UTMD's latest filing, up from 28.35% in the prior quarter.
  • Across five years, FCF Margin topped out at 54.89% in Q1 2023 and bottomed at 25.5% in Q2 2024.
  • Average FCF Margin over 5 years is 39.52%, with a median of 39.25% recorded in 2025.
  • Peak YoY movement for FCF Margin: crashed -1135bps in 2022, then surged 1586bps in 2023.
  • A 5-year view of FCF Margin shows it stood at 36.66% in 2021, then grew by 13bps to 41.56% in 2022, then rose by 2bps to 42.5% in 2023, then dropped by -25bps to 31.97% in 2024, then grew by 23bps to 39.25% in 2025.
  • Per Business Quant database, its latest 3 readings for FCF Margin were 39.25% in Q3 2025, 28.35% in Q2 2025, and 44.08% in Q1 2025.